Jam

Faraday Future (FFAI) appointed Chris Nixon Cox as a global strategic advisor, effective November 3, 2025. Cox will focus on bolstering international expansion by fostering investor relations, navigating governmental affairs, and cultivating industrial cooperation. His role supports FFAI’s “EAI + Crypto” strategy, emphasizing AI-driven innovations and cryptocurrency integration. Cox will join the planned FFAI Global Strategic Advisory Council. This appointment aims to accelerate the company’s global deployment strategy and secure sustainable growth in the EV market.

Northern Trust expands its partnership with Avanda Investment Management to support a mandate from the Monetary Authority of Singapore (MAS) under the Equity Market Development Programme (EQDP). Northern Trust will provide investment operations outsourcing, fund administration, and risk analytics, building on a decade-long relationship. The EQDP is a S$5 billion initiative aimed at strengthening Singapore’s asset management ecosystem. Avanda’s strategy under the EQDP seeks to increase investor access to Singapore-listed equities. This collaboration underscores Northern Trust’s commitment to the Southeast Asian financial market.

Alvotech (ALVO) received a Complete Response Letter from the FDA for its AVT05 biosimilar application, citing deficiencies from a July 2025 facility inspection in Reykjavik. No other application deficiencies were noted, and the facility retains FDA approval for existing product manufacturing. Alvotech submitted a CAPA plan. The company revised its 2025 financial outlook to $570-600 million in revenue and $130-150 million adjusted EBITDA, reflecting facility investments and a temporary production slowdown. US sales of reference product Simponi were <$300M in 1H 2025; no Simponi biosimilar is approved in the US.

Caribou Biosciences (CRBU) will host a webcast on November 3, 2025, to report clinical data from the ANTLER Phase 1 trial of vispa-cel (CB-010) in relapsed/refractory B-NHL and first-time clinical data from the CaMMouflage Phase 1 trial of CB-011 in relapsed/refractory multiple myeloma. The Company will also outline the Phase 3 trial design for vispa-cel and development plans for CB-011. The webcast will be available live and archived on Caribou’s website.

Tenaris (TS) has initiated the second $600 million tranche of its $1.2 billion share buyback program, scheduled from November 3, 2025, to April 30, 2026. A financial institution will execute the buyback independently, adhering to regulations and potentially purchasing shares during closed periods. Repurchased shares will be canceled, reducing the outstanding share count. The buyback, authorized by shareholders, aims to return capital, but faces risks linked to oil and gas prices.

Belite Bio (BLTE) announced that the UK’s MHRA agreed to accept a Conditional Marketing Authorization application for Tinlarebant to treat Stargardt disease, based on Phase 3 DRAGON interim analysis. The DRAGON trial enrolled 104 subjects across 11 jurisdictions. Topline final data is expected in Q4 2025, which will be submitted to MHRA for full Marketing Authorization. This regulatory milestone offers a faster route to market but depends on positive final data.

Travelzoo (TZOO) has launched new, exclusive Club Offers for U.S. members, providing curated travel deals. These include discounted packages to Portugal ($499), Bali (under $500 for two), and Hawaii ($799), alongside hotel stays across the U.S. for $99 or less and half-off treatments at 500+ spas. Savings are significant, but availability is limited. Travelzoo aims to capitalize on the travel industry’s recovery by offering value and unique experiences to its members.

Travelzoo (TZOO) announced new Club Offers for UK members on Nov 1, 2025, featuring curated travel deals. Offers include a Yorkshire manor escape for £69, a luxury Portuguese wine estate stay for £305pp, and a French Alps ski week with flights for £499pp. Other offers feature trips to the Spanish countryside and West End show with dinner. The deals, vetted by Travelzoo’s experts, aim to provide significant savings capitalizing on the increasing demand for value-driven travel experiences.

Tractor Supply Company celebrated National Hometown Heroes Day across 2,300+ stores, donating $500 per store to local fire, police, and veteran organizations – totaling over $1 million. The celebrations included Touch-a-Truck events, thank-you note stations, and a digital “Honor Wall”, uniting communities to recognize their local heroes. The initiative reflects the company’s strategic focus on rural communities and its commitment to social responsibility, fostering customer loyalty and brand affinity. Tractor Supply has donated over $3 million to support military personnel, veterans, and first responders since the initiative began in 2024.

Ibotta launches its sixth annual “Thanksgiving on Us” campaign on November 1, 2025, offering cash-back rewards on Thanksgiving grocery essentials amid rising inflation concerns. New users can potentially earn over $22 in rewards on staples. Existing users get cashback on side dishes and turkey opportunities via referrals. Ibotta is also donating $50,000 to Feeding America’s Community Response Fund. The company aims to ease financial strain on families and reinforces its commitment to social responsibility.